Who owns SPDR S&P Pharmaceuticals?
- Ticker: XPH
- CUSIP Number: 78464A722
Tip: Access positions for across all investors
Analyze quarterly positions in SPDR S&P Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of SPDR S&P Pharmaceuticals stock
Who bought or sold SPDR S&P Pharmaceuticals this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Envestnet Asset Management | 247k | $14M | 10% | Dec 2025 |
|
| LPL Financial | 208k | $12M | 13% | Dec 2025 |
|
| Wells Fargo & Company | 207k | $12M | 176% | Dec 2025 |
|
| First Citizens Bank & Trust | 186k | $10M | 3% | Dec 2025 |
|
| Envestnet Portfolio Solutions | 175k | $9.8M | 2% | Dec 2025 |
|
| Susquehanna International | 98k | $5.5M | 6% | Dec 2025 |
|
| Bnp Paribas Arbitrage, Snc | 90k | $5.0M | 124% | Dec 2025 |
|
| Cetera Investment Advisers | 81k | $4.5M | 17% | Dec 2025 |
|
| Jpmorgan Chase & Co | 59k | $2.8M | 100% | Sep 2025 |
|
| UBS Group | 48k | $2.7M | 33% | Dec 2025 |
|
| Clark Capital Management Group | 47k | $2.2M | 100% | Sep 2025 |
|
| Wharton Business Group | 46k | $2.6M | -9% | Dec 2025 |
|
| Bp Wealth Management | 44k | $2.4M | 4% | Dec 2025 |
|
| Mml Investors Services | 33k | $1.8M | 25% | Dec 2025 |
|
| Goldman Sachs Group | 31k | $1.7M | -73% | Dec 2025 |
|
| MAI Wealth Advisors | 30k | $1.7M | -2% | Dec 2025 |
|
| Baird Financial | 29k | $1.6M | 456% | Dec 2025 |
|
| Royal Bank of Canada | 27k | $1.3M | 0% | Sep 2025 |
|
| Jane Street | 26k | $1.4M | 100% | Dec 2025 |
|
| Gts Securities | 23k | $1.3M | -19% | Dec 2025 |
|
| Stifel Financial | 21k | $1.1M | 100% | Dec 2025 |
|
| Rockefeller Capital Management | 20k | $1.1M | 3% | Dec 2025 |
|
| Compass Wealth Management | 18k | $992k | 100% | Dec 2025 |
|
| Raymond James Financial | 15k | $818k | -11% | Dec 2025 |
|
| U.S. Capital Wealth Advisors | 14k | $808k | -2% | Dec 2025 |
|
| Park Avenue Securities | 12k | $673k | 19% | Dec 2025 |
|
| Pnc Financial Services | 12k | $669k | -35% | Dec 2025 |
|
| CX Institutional | 7.6k | $428k | -85% | Dec 2025 |
|
| Fragasso | 6.7k | $375k | 0% | Dec 2025 |
|
| Principal Securities | 6.2k | $345k | 18% | Dec 2025 |
|
| Sigma Planning | 5.9k | $333k | 2% | Dec 2025 |
|
| Advisor Group Holdings | 5.9k | $333k | -57% | Dec 2025 |
|
| Citadel Advisors | 5.7k | $275k | -85% | Sep 2025 |
|
| EP Wealth Advisors | 5.7k | $319k | -17% | Dec 2025 |
|
| Branch Banking & Trust Company | 5.1k | $284k | 0% | Dec 2025 |
|
| Colony | 4.7k | $265k | 100% | Dec 2025 |
|
| Janney Montgomery Scott | 4.4k | $249k | 2% | Dec 2025 |
|
| Florida Financial Advisors | 4.4k | $244k | 100% | Dec 2025 |
|
| CLS Investments | 4.4k | $244k | 100% | Dec 2025 |
|
| Evelyn Partners Investment Management | 4.3k | $238k | -8% | Dec 2025 |
|
| Stephens | 4.1k | $229k | 100% | Dec 2025 |
|
| NewEdge Wealth | 4.0k | $226k | -64% | Dec 2025 |
|
| Vista Investment Management | 4.0k | $223k | 100% | Dec 2025 |
|
| Cambridge Investment Research Advisors | 4.0k | $222k | 100% | Dec 2025 |
|
| Atlantic Trust | 2.9k | $163k | 3% | Dec 2025 |
|
| FMR | 2.8k | $135k | -13% | Sep 2025 |
|
| Kestra Advisory Services | 2.7k | $151k | 100% | Dec 2025 |
|
| National Bank Of Canada /fi/ | 2.5k | $140k | 2% | Dec 2025 |
|
| Jones Financial Companies, L.L | 1.7k | $96k | 28% | Dec 2025 |
|
| Nbc Securities | 1.6k | $87k | -12% | Dec 2025 |
|
| Team Financial Group | 1.0k | $56k | 100% | Dec 2025 |
|
| William Blair $ Company | 851.00 | $41k | 0% | Sep 2025 |
|
| Northwestern Mutual Wealth Management Company | 821.00 | $46k | 0% | Dec 2025 |
|
| Hanson McClain Advisors | 790.00 | $44k | 0% | Dec 2025 |
|
| Whittier Trust | 619.00 | $34k | -5% | Dec 2025 |
|
| Brian McDonald | 594.00 | $33k | 0% | Dec 2025 |
|
| AE Wealth Management | 452.00 | $25k | 0% | Dec 2025 |
|
| Federation des caisses Desjardins du Quebec | 400.00 | $22k | 0% | Dec 2025 |
|
| Alerus Financial | 375.00 | $21k | 0% | Dec 2025 |
|
| Cape Investment Advisory | 238.00 | $13k | 100% | Dec 2025 |
|
| CWM | 200.00 | $11k | 0% | Dec 2025 |
|
| Addison Advisors | 188.00 | $11k | 0% | Dec 2025 |
|
| Steward Partners Investment Advisory | 179.00 | $10k | 0% | Dec 2025 |
|
| Global Retirement Partners | 103.00 | $5.7k | -9% | Dec 2025 |
|
| Darren Munn | 77.00 | $4.3k | 100% | Dec 2025 |
|
| O'shaughnessy Asset Management | 65.00 | $3.6k | 0% | Dec 2025 |
|
| CoreCap Advisors | 41.00 | $2.3k | 0% | Dec 2025 |
|
| Jackson Hole Capital Partners | 35.00 | $2.0k | 0% | Dec 2025 |
|
| Front Row Advisors | 18.00 | $1.0k | 0% | Dec 2025 |
|
| Qube Research & Technologies | 6.00 | $336.000000 | 200% | Dec 2025 |
|
| Huntington National Bank | 1.00 | $56.000000 | 0% | Dec 2025 |
|
Who sold out of SPDR S&P Pharmaceuticals?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Concurrent Investment Advisors | Sep 2025 | 8.1k | $388k |
| Advantage Trust | Sep 2025 | 3.3k | $156k |
| Advisory Services Network | Sep 2025 | 700.00 | $34k |
| Sontag Advisory | Sep 2025 | 402.00 | $19k |
| Goss Wealth Management | Sep 2025 | 260.00 | $13k |
| Ronald Blue Trust | Sep 2025 | 145.00 | $7.0k |
| Tower Research Capital | Sep 2025 | 2.00 | $96.000000 |